A dual readout embryonic zebrafish xenograft model of rhabdomyosarcoma to assess clinically relevant multi-receptor tyrosine kinase inhibitors
Joseph W. Wragg, Emma Gray, Rui M. Monteiro, Joanna R. Morris, Andrew David Beggs, Ferenc Müller, Susanne A. Gatz
This paper develops an embryonic zebrafish xenograft model to assess the efficacy of multi-receptor tyrosine kinase inhibitors in rhabdomyosarcoma, identifying VEGF-A as a potential biomarker for Regorafenib response.
Frontiers in Oncology · May 21, 2025Peer-reviewedCancer Biology